{"disease":{"id":"irritable-bowel-syndrome-with-diarrhea","name":"Irritable bowel syndrome with diarrhea","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"rifaximin","indication_name":"Irritable bowel syndrome with diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xifaxan","generic_name":"rifaximin","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 1 group I member 2, Bacterial DNA-directed RNA polymerase","drug_class":"Rifamycin Antibacterial [EPC]","quality_score":10,"revenue":"1500","mechanism":null},{"drug_id":"eluxadoline","indication_name":"Irritable bowel syndrome with diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Viberzi","generic_name":"ELUXADOLINE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"mu-Opioid Receptor Agonist [EPC]","quality_score":48,"revenue":null,"mechanism":"Viberzi works by activating the mu-opioid receptor in the gut to slow down bowel movements and reduce diarrhea."},{"drug_id":"xifaxan","indication_name":"Irritable bowel syndrome with diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xifaxan","company_name":"Children's Hospital Los Angeles","drug_phase":"discontinued","molecular_target":"Nuclear receptor subfamily 1 group I member 2, Bacterial DNA-directed RNA polymerase","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"alosetron","indication_name":"Irritable bowel syndrome with diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotronex","generic_name":"ALOSETRON","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"Serotonin-3 Receptor Antagonist","quality_score":66,"revenue":null,"mechanism":"Lotronex works by blocking serotonin receptors in the gut to slow down bowel movements."},{"drug_id":"rifaximine","indication_name":"Irritable bowel syndrome with diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rifaximine","company_name":"Ain Shams University","drug_phase":"phase_2","molecular_target":"Nuclear receptor subfamily 1 group I member 2, Bacterial DNA-directed RNA polymerase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03931785","title":"A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06153420","title":"Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":421,"lead_sponsor_name":"CinPhloro Pharma, LLC","has_results":false},{"nct_id":"NCT06960369","title":"Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT02959983","title":"Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":346,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT04129619","title":"A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"OrphoMed, Inc.","has_results":false},{"nct_id":"NCT04950296","title":"To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Vedic Lifesciences Pvt. Ltd.","has_results":false},{"nct_id":"NCT04492787","title":"Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Tasly Pharmaceutical Group Co., Ltd","has_results":false},{"nct_id":"NCT05339243","title":"Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Vedic Lifesciences Pvt. Ltd.","has_results":false},{"nct_id":"NCT06612411","title":"B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT04053790","title":"Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Hospital General de Mexico","has_results":false},{"nct_id":"NCT05867550","title":"To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Bahria University","has_results":false},{"nct_id":"NCT03729271","title":"Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT02757105","title":"Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"RedHill Biopharma Limited","has_results":true},{"nct_id":"NCT03997708","title":"A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Attikon Hospital","has_results":false},{"nct_id":"NCT05523427","title":"Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Mosul","has_results":false},{"nct_id":"NCT05646186","title":"Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Istanbul Medipol University Hospital","has_results":false},{"nct_id":"NCT07103772","title":"Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":94,"lead_sponsor_name":"Universidad Autonoma de Nuevo Leon","has_results":false},{"nct_id":"NCT07052890","title":"Curcumin, Vitamin D and Green Tea in IBS-D","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Dr Anthony Hobson","has_results":false},{"nct_id":"NCT05702255","title":"Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT04830410","title":"The Effects of Carbohydrates in Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT04899869","title":"Faecal Microbiota Transplantation in Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Thomayer University Hospital","has_results":false},{"nct_id":"NCT05379036","title":"Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT04484467","title":"Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Federal Stare Budgetary Scientific Institution, Mental Health Research Center","has_results":false},{"nct_id":"NCT04662957","title":"Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Children's Memorial Health Institute, Poland","has_results":false},{"nct_id":"NCT06432569","title":"Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Padova","has_results":false},{"nct_id":"NCT05754177","title":"Safety and Efficacy of a Probiotic Supplement in IBS-D","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"The Archer-Daniels-Midland Company","has_results":false},{"nct_id":"NCT04557215","title":"Efficacy and Safety of Rifaximin With NAC in IBS-D","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":true},{"nct_id":"NCT04806386","title":"The Role of Fiber in the Prevention and Treatment of Fecal Incontinence","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04855799","title":"GI Permeability Change in Response to Aquamin®","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"James Varani","has_results":false},{"nct_id":"NCT03806959","title":"Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Hospital Avicenne","has_results":false},{"nct_id":"NCT03557788","title":"Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false},{"nct_id":"NCT06543498","title":"The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Dr Anthony Hobson","has_results":false},{"nct_id":"NCT03270085","title":"Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT05130047","title":"Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Michael Camilleri, MD","has_results":true},{"nct_id":"NCT03245645","title":"FODMAP Reintroduction in Irritable Bowel Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT05277428","title":"Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Amorepacific Corporation","has_results":false},{"nct_id":"NCT03441581","title":"Eluxadoline Bile Acid Malabsorption (BAM) Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03221790","title":"Effect of FODMAPs on Mucosal Inflammation in IBS Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Queen's University","has_results":false},{"nct_id":"NCT05453916","title":"Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Sadat City University","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}